Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer
Clinical trial NCT01493843 · COMPLETED
Trial details
- NCT number
- NCT01493843
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-20
- Primary completion
- 2016-03-30
- Enrollment
- 501
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.